Mistletoe therapy in oncology.

The Cochrane Database of Systematic Reviews
M A HorneberM Rostock

Abstract

Mistletoe extracts are commonly used in cancer patients. It is claimed that they improve survival and quality of life (QOL) in cancer patients. To determine the effectiveness, tolerability and safety of mistletoe extracts given either as monotherapy or adjunct therapy for patients with cancer. Search sources included the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 3, 2007) Cochrane Complementary Medicine Field Registry of randomized clinical trials (RCTs) and controlled clinical trials, MEDLINE, EMBASE, HEALTHSTAR, INT. HEALTH TECHNOLOGY ASSESSMENT, SOMED, AMED, BIOETHICSLINE, BIOSIS, CancerLit, CATLINE, CISCOM (August 2007). For the search the Standard Operating Procedures of the Information System in Health Economics at the German Institute for Medical Documentation and Information (DIMDI) were utilized. Reference lists of relevant articles and authors extensive files were searched for additional studies. Manufacturers of mistletoe preparations were contacted. We included RCTs of adults with cancer of any type. The interventions were mistletoe extracts as sole treatments or given concomitantly with chemo- or radiotherapy. The outcome measures were survival times, tumor response, QOL, psychological distress,...Continue Reading

Associated Clinical Trials

References

Nov 1, 1978·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J L HaywardA Segaloff
Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Jun 1, 1996·American Journal of Clinical Oncology·D J VaughnD G Haller
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Aug 1, 1997·Journal of Medical Genetics·J E AllansonM Ireland
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M K Steuer-VogtW Arnold
May 9, 2001·The Journal of Urology·K N GanjooL H Einhorn
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A RavaudUNKNOWN EORTC-ECSG
Mar 22, 2002·The Lancet Oncology·H Kiene
Jan 8, 2003·Seminars in Oncology·Patrick J Mansky
Feb 1, 2003·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Takafumi YayamaHisatoshi Baba
Apr 2, 2003·Cancer Biotherapy & Radiopharmaceuticals·Mircea CazacuNeven Zarkovic
Jun 18, 2003·Spine·Maurits van TulderUNKNOWN Editorial Board of the Cochrane Collaboration Back Review Group
Sep 2, 2003·International Journal of Cancer. Journal International Du Cancer·Eduard ErnstMiriam Katharina Steuer-Vogt
Jan 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U R KleebergUNKNOWN EORTC Melanoma Group in cooperation with the German Cancer Society (DKG)
Jul 14, 2004·Forschende Komplementärmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine·I GerhardJ J Kuehn
May 26, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P SchöffskiH Lentzen
Jun 11, 2005·The Journal of Urology·Ursula Elsässer-BeileUlrich Wetterauer
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulrich KeilholzAlexander M M Eggermont
Mar 8, 2006·Annals of Internal Medicine·Joel J GagnierUNKNOWN CONSORT Group
Oct 24, 2006·Forschende Komplementärmedizin = Research in Complementary Medicine·Ronald Grossarth-Maticek, Renatus Ziegler
Dec 23, 2006·BMJ : British Medical Journal·Edzard Ernst
Jun 29, 2007·Forschende Komplementärmedizin = Research in Complementary Medicine·Ronald Grossarth-Maticek, Renatus Ziegler
Mar 13, 2008·Forschende Komplementärmedizin = Research in Complementary Medicine·Annette Loewe-MeschCornelia v Hagens
Dec 1, 1994·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·J Kleijnen, P Knipschild
Aug 1, 2003·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Yong Wan KimWoong Shick Ahn

❮ Previous
Next ❯

Citations

Aug 30, 2011·BMC Complementary and Alternative Medicine·Gunver S KienleHelmut Kiene
Feb 28, 2014·European Journal of Pediatrics·Hwa Jin ChoIn Seok Jeong
Aug 20, 2014·BioMed Research International·Mohsen MarvibaigiSaravana Kumar Jaganathan
Nov 29, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Patrick J ManskyBrian P Monahan
Jul 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Guo-Shiou LiaoLie-Fen Shyur
Aug 23, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ya Chee LimSheba R David
Feb 10, 2017·The Korean Journal of Thoracic and Cardiovascular Surgery·Dongsub NohDoo Yun Lee
Jul 8, 2011·Integrative Cancer Therapies·Mathias BrandenbergerReinhard Saller
Mar 3, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tammy YauTzi Bun Ng
Apr 17, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wenyan Xie, Matthias F Melzig
Aug 30, 2017·World Journal of Clinical Oncology·Akbar KhanAnneke C Blackburn
Apr 8, 2017·The Cochrane Database of Systematic Reviews·Cathy PayneSuzanne Martin
May 15, 2010·European Journal of Clinical Pharmacology·Roman HuberChristoph H Gleiter
Apr 3, 2019·BMJ Case Reports·Jens KaestnerBernd Gruhn
Sep 1, 2012·Chinese Journal of Integrative Medicine·Gustav J DobosKyung-Eun Choi
Feb 12, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C ShneersonN Gale
Mar 31, 2015·Natural Product Research·Jolanta Nazaruk, Przemysław Orlikowski
Oct 27, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Shiao Li OeiFriedemann Schad
Jul 2, 2020·Cells·Ling MaDavid Vermijlen
Apr 8, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Anja ThronickeFriedemann Schad
May 24, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Shiao Li OeiFriedemann Schad
Jul 19, 2017·PloS One·Carmen SteinbornCarsten Gründemann
Jun 10, 2017·Experimental and Therapeutic Medicine·Leoni Villano BonaminSilvia Waisse
Jul 22, 2020·BMC Complementary Medicine and Therapies·Martin Loef, Harald Walach
Jul 16, 2019·Journal of Cancer Research and Clinical Oncology·Jutta HuebnerJ Buentzel
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tahani MaherArifullah Mohammed
Jun 16, 2021·Der Urologe. Ausg. A·Jutta HübnerChristian Keinki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
E Ernst
Journal of Neurology, Neurosurgery, and Psychiatry
L F Haas
BMJ : British Medical Journal
E Ernst
Deutsche medizinische Wochenschrift
Daniela Umbreit
© 2022 Meta ULC. All rights reserved